Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
Dipen J. Parekh(University of Miami), Isildinha M. Reis(University of Miami), Erik P. Castle(WinnMed), Mark L Gonzalgo(University of Miami), Michael Woods(University of North Carolina at Chapel Hill), Robert S. Svatek(The University of Texas at San Antonio Health Science Center), Alon Z. Weizer(University of Michigan), Badrinath R. Konety(University of Minnesota), Mathew Tollefson(WinnMed), Tracey L. Krupski(University of Virginia), Norm D. Smith(University of Chicago), Ahmad Shabsigh(The Ohio State University), Daniel A. Barocas(Vanderbilt University Medical Center), Marcus L. Quek(Loyola University Medical Center), Atreya Dash(University of Washington), Adam S. Kibel(Brigham and Women's Hospital), Lynn Shemanski(Cancer Research And Biostatistics), Raj S. Pruthi(University of North Carolina at Chapel Hill), Jeffrey S. Montgomery(University of Michigan), Christopher Weight(University of Minnesota), David S. Sharp(The Ohio State University), Sam S. Chang(Vanderbilt University Medical Center), Michael S. Cookson(University of Oklahoma), Gopal N. Gupta(Loyola University Medical Center), Alex Gorbonos(Loyola University Medical Center), Edward Uchio(University of California, Irvine), Eila C. Skinner(Stanford University), Vivek Venkatramani(University of Miami), Nachiketh Soodana‐Prakash(University of Miami), Kerri Kendrick(The University of Texas at San Antonio Health Science Center), Joseph A. Smith(Vanderbilt University Medical Center), Ian M. Thompson(The University of Texas at San Antonio Health Science Center)
Cited by 759